Recent investigations have converged on the intersection of glucagon-like peptide-1|glucose-dependent insulinotropic polypeptide|glucagon receptor agonist therapies and DA neurotransmission. While GIP agonists are https://minaxjvf952660.prublogger.com/39891868/novel-glp-agonists-and-dopaminergic-influence-a-relative-assessment